Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-8-26
pubmed:abstractText
Standardized enumeration of CEC counts is required to minimize variability and allow cross-studies comparisons. The purpose of this paper is to identify CEC threshold proposal, by CellSearch system, for determining response to bevacizumab-based chemotherapy in metastatic colorectal cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1432-0843
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
763-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21170650-Adolescent, pubmed-meshheading:21170650-Adult, pubmed-meshheading:21170650-Aged, pubmed-meshheading:21170650-Angiogenesis Inhibitors, pubmed-meshheading:21170650-Antibodies, Monoclonal, pubmed-meshheading:21170650-Antibodies, Monoclonal, Humanized, pubmed-meshheading:21170650-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21170650-Cell Count, pubmed-meshheading:21170650-Cell Separation, pubmed-meshheading:21170650-Colorectal Neoplasms, pubmed-meshheading:21170650-Disease-Free Survival, pubmed-meshheading:21170650-Endothelial Cells, pubmed-meshheading:21170650-Female, pubmed-meshheading:21170650-Fluorouracil, pubmed-meshheading:21170650-Humans, pubmed-meshheading:21170650-Kaplan-Meier Estimate, pubmed-meshheading:21170650-Leucovorin, pubmed-meshheading:21170650-Male, pubmed-meshheading:21170650-Middle Aged, pubmed-meshheading:21170650-Neoplasm Metastasis, pubmed-meshheading:21170650-Organoplatinum Compounds, pubmed-meshheading:21170650-Predictive Value of Tests, pubmed-meshheading:21170650-Prospective Studies, pubmed-meshheading:21170650-Regression Analysis, pubmed-meshheading:21170650-Survival Analysis, pubmed-meshheading:21170650-Young Adult
pubmed:year
2011
pubmed:articleTitle
Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer.
pubmed:affiliation
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't